Central venous access ports in children treated for hematopoietic malignancies

Pediatric Hematology and Oncology

Volumn 25, Issue 8, 2008, Pages 751-755

  Bucki, Bogusław ^a   Tomaszewska, Renata ^a   Karpe, Jacek ^a   Stoksik, Piotr ^a   Sońta Jakimczyk, Danuta ^a   Szczepański, Tomasz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Central venous access port; Childhood cancer; Complications

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRAIN TUMOR; CANCER PATIENT; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HISTIOCYTOSIS X; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; SUBCLAVIAN VEIN;

ADOLESCENT; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INFECTION; MALE;

EID: 57449090204     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010802313632     Document Type: Article

References (17)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-178.
2. Winick NJ, Carroll WL, Hunger SP. Childhood leukemia: new advances and challenges. N Engl J Med. 2004;351:601-603.
3. Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol. 1999;17:1267-1273.
4. Carr E, Jayabose S, Stringel G, et al. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006;47:886-888.
5. Krzywda EA, Andris DA. Twenty-five years of advances in vascular access: Bridging research to clinical practice. Nutr Clin Pract. 2005;20:597-606.
6. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol. 2005;23:3024-3029.
7. Nouwen JL, Wielenga JJ, van Overhagen H, et al. Hickman catheter-related infections in neutropenic patients: Insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol. 1999;17:1304-1311.
8. Nosher JL, Bodner LJ, Ettinger LJ, et al. Radiologic placement of a low profile implantable venous access port in a pediatric population. Cardiovasc Intervent Radiol. 2001;24:395-399.
9. Lorenz JM, Funaki B, Van Ha T, et al. Radiologic placement of implantable chest ports in pediatric patients. AJR Am J Roentgenol. 2001;176:991-994.
10. Flynn PM, Willis B, Gaur AH, et al. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol. 2003;21:3520-3525.
11. Bodner LJ, Nosher JL, Patel KM, et al. Peripheral venous access ports: Outcomes analysis in 109 patients. Cardiovasc Intervent Radiol. 2000;23:187-193.
12. Munro FD, Gillett PM, Wratten JC, et al. Totally implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol. 1999;33:377-381.
13. Biffi R, Corrado F, de Braud F, et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device. Eur J Cancer. 1997;33:1190-1194.
14. Kock HJ, Pietsch M, Krause U, et al. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12-16.
15. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62:358-365.
16. Babu R, Spicer RD. Implanted vascular access devices (ports) in children: Complications and their prevention. Pediatr Surg Int. 2002;18:50-53.
17. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665-3675.